home / stock / vphif / vphif quote
Last: | $0.0376 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0376 |
Close: | $0.0376 |
High: | $0.0376 |
Low: | $0.0376 |
Volume: | 6,500 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0376 | $0.0376 | $0.0376 | $0.0376 | $0.0376 | 6,500 | 07-16-2024 |
$0.0775 | $0.0775 | $0.0775 | $0.0775 | $0.0775 | 440 | 07-10-2024 |
$0.0982 | $0 | $0.0982 | $0 | $0 | 22,500 | 06-27-2024 |
$0.0982 | $0.0885 | $0.0982 | $0.0982 | $0.0885 | 21,000 | 06-21-2024 |
$0.0964 | $0.09635 | $0.09635 | $0.0964 | $0.0964 | 10,000 | 06-19-2024 |
$0.09635 | $0.09635 | $0.09635 | $0.09635 | $0.09635 | 10,000 | 06-18-2024 |
$0.1039 | $0.1039 | $0.1039 | $0.1039 | $0.1039 | 830 | 06-14-2024 |
$0.1181 | $0.1181 | $0.1181 | $0.1181 | $0.1181 | 4,510 | 06-13-2024 |
$0.0603 | $0.0603 | $0.0603 | $0.0603 | $0.0603 | 670 | 06-10-2024 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 35,000 | 05-22-2024 |
$0.07 | $0 | $0.07 | $0 | $0 | 10 | 05-20-2024 |
$0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 1,030 | 05-17-2024 |
$0.0716 | $0.0716 | $0.0716 | $0.0716 | $0.0716 | 10,000 | 05-16-2024 |
$0.0679 | $0.06825 | $0.0679 | $0.06825 | $0.0679 | 10,000 | 05-15-2024 |
$0.06795 | $0.06795 | $0.06795 | $0.06795 | $0.06795 | 10,000 | 05-14-2024 |
$0.0483 | $0.0483 | $0.0483 | $0.0483 | $0.0483 | 1,300 | 05-09-2024 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 3,000 | 05-02-2024 |
$0.03432 | $0.08 | $0.03432 | $0.08 | $0.03432 | 1,000 | 05-01-2024 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 1,500 | 04-29-2024 |
$0.105 | $0.105 | $0.105 | $0.105 | $0.105 | 17,000 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...